- Home
- BOTJ vs IVVD Comparison
BOTJ vs IVVD Comparison
Compare BOTJ & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOTJ
- IVVD
- Stock Information
- Founded
- BOTJ 1998
- IVVD 2020
- Country
- BOTJ United States
- IVVD United States
- Employees
- BOTJ N/A
- IVVD N/A
- Industry
- BOTJ Major Banks
- IVVD Biotechnology: Pharmaceutical Preparations
- Sector
- BOTJ Finance
- IVVD Health Care
- Exchange
- BOTJ Nasdaq
- IVVD Nasdaq
- Market Cap
- BOTJ 62.8M
- IVVD 69.0M
- IPO Year
- BOTJ N/A
- IVVD 2021
- Fundamental
- Price
- BOTJ $14.50
- IVVD $0.86
- Analyst Decision
- BOTJ
- IVVD Strong Buy
- Analyst Count
- BOTJ 0
- IVVD 3
- Target Price
- BOTJ N/A
- IVVD $7.52
- AVG Volume (30 Days)
- BOTJ 2.3K
- IVVD 2.3M
- Earning Date
- BOTJ 04-30-2025
- IVVD 05-15-2025
- Dividend Yield
- BOTJ 2.76%
- IVVD N/A
- EPS Growth
- BOTJ N/A
- IVVD N/A
- EPS
- BOTJ 1.45
- IVVD N/A
- Revenue
- BOTJ $45,083,000.00
- IVVD $25,384,000.00
- Revenue This Year
- BOTJ N/A
- IVVD $606.63
- Revenue Next Year
- BOTJ N/A
- IVVD $83.30
- P/E Ratio
- BOTJ $9.81
- IVVD N/A
- Revenue Growth
- BOTJ 4.72
- IVVD N/A
- 52 Week Low
- BOTJ $10.14
- IVVD $0.36
- 52 Week High
- BOTJ $17.05
- IVVD $2.74
- Technical
- Relative Strength Index (RSI)
- BOTJ 60.84
- IVVD 67.72
- Support Level
- BOTJ $14.00
- IVVD $0.52
- Resistance Level
- BOTJ $14.40
- IVVD $0.80
- Average True Range (ATR)
- BOTJ 0.34
- IVVD 0.10
- MACD
- BOTJ 0.07
- IVVD 0.03
- Stochastic Oscillator
- BOTJ 86.21
- IVVD 61.62
About BOTJ Bank of the James Financial Group Inc.
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.